Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqory’s TROP2 Antibody Drug Conjugate, OQY-3258
OQY-3258, also known as ESG401, is an anti-TROP2 ADC currently under evaluation in three clinical trials: A Phase 1a/1b clinical trial for patients with solid tumors (NCT04892342). A Phase 3 study in ...
NBA trade deadline 2025: The 5 most fascinating teams to watch
The 2025 NBA trade deadline is just over a week away, and just about every team in the league is looking to play some kind of ...
financefeeds17h
Which Crypto Will Boom in 2025? Spotting the Next 100x Opportunity
Bitcoin (BTC) has just smashed through the $100,000 mark, and the crypto world is buzzing. Social media is ablaze with posts ...
Copenhagen Post9h
Greenlandic member of parliament reported for defamation
An internal dispute between two Greenlandic members of parliament has flared up after Donald Trump declared his interest in taking over Greenland.Kuno Fencker has reported Aaja Chemnitz, a member of ...